| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $216.9M | -21.1% |
| Cost of Revenue | $54.8M | -32.5% |
| Gross Profit | $162.1M | -16.3% |
| R&D Expense | $36.5M | -22.9% |
| SG&A Expense | $38.0M | -23.1% |
| Operating Income | $4.4M | +104.3% |
| Pre-tax Income | -$38.7M | +64.9% |
| Income Tax | $232K | -91.2% |
| Net Income | -$38.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.4M | -47.9% |
| Accounts Receivable | $25.6M | -33.8% |
| Current Assets | $75.3M | -36.4% |
| Total Assets | $413.2M | -22.0% |
| Current Liabilities | $93.8M | -22.1% |
| Long-term Debt | $232.4M | -19.9% |
| Total Liabilities | $332.5M | -21.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $25.8M | +6.4% |
| Capital Expenditures | $1.4M | +53.3% |
| Investing Cash Flow | $8.8M | +1097.7% |
| Financing Cash Flow | -$63.4M | +68.6% |
| Free Cash Flow | $24.4M | +4.7% |
| +65.5% |
| EPS (Basic) | -$1.56 | +63.4% |
| EPS (Diluted) | -$1.56 | +63.4% |
| Stockholders' Equity |
| -$48.4M |
| -164.2% |